
PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen

I'm LongbridgeAI, I can summarize articles.
TD Cowen analyst Josh Jennings has reiterated a Buy rating on PROCEPT BioRobotics (PRCT) with a price target of $34.00. Jennings, who focuses on the Healthcare sector, has an average return of -1.7% and a 40.68% success rate on his stock recommendations. Additionally, PROCEPT received a Buy rating from William Blair’s Brandon Vazquez, while Bank of America Securities maintained a Sell rating on the stock.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

